Lookup NU author(s): Professor Jeremy Parr
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
In recent years, understanding of the pathogenesis and clinical presentation of distinct myasthenia subtypes has increased significantly. This article reviews the clinical manifestations of autoimmune myasthenia gravis (including myasthenia associated with anti-muscle-specific kinase antibodies), ocular myasthenia, and antibody negative myasthenia. The following treatments are examined: cholinesterase inhibitors, immunosuppressants, and thymectomy. Inherited congenital myasthenic syndromes (CMS) are now increasingly recognized, and most commonly present during childhood. This article outlines the presynaptic, synaptic basal lamina-associated, and postsynaptic classification of CMS and the clinical presentation and aetiology of individual syndromes. Relevant investigations and treatment options (including the role of pyridostigmine, 3,4-diaminopyridine, fluoxetine, and ephedrine) are discussed.
Author(s): Parr JR, Jayawant S
Publication type: Article
Publication status: Published
Journal: Developmental Medicine and Child Neurology
ISSN (print): 0012-1622
ISSN (electronic): 1469-8749
Publisher: Mac Keith Press
Altmetrics provided by Altmetric